Journal articles on the topic 'Facial hyperkinesis'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Facial hyperkinesis.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
May, Mark. "Management of Facial Hyperkinesis." Otology & Neurotology 23, Sup 1 (2002): S70. http://dx.doi.org/10.1097/00129492-200200001-00179.
Full textFilipo, Roberto, Irma Spahiu, Edoardo Covelli, Maria Nicastri, and Gian Antonio Bertoli. "Botulinum toxin in the treatment of facial synkinesis and hyperkinesis." Laryngoscope 122, no. 2 (2012): 266–70. http://dx.doi.org/10.1002/lary.22404.
Full textde Maio, Maur??cio, and Ricardo Ferreira Bento. "Botulinum Toxin in Facial Palsy: An Effective Treatment for Contralateral Hyperkinesis." Plastic and Reconstructive Surgery 120, no. 4 (2007): 917–27. http://dx.doi.org/10.1097/01.prs.0000244311.72941.9a.
Full textKim, Jin. "Prevention and Treatment of Post-Paralytic Synkinesis: Critical Changes Following Severe Facial Palsy." Journal of Electrodiagnosis and Neuromuscular Diseases 26, no. 2 (2024): 19–24. http://dx.doi.org/10.18214/jend.2024.00038.
Full textЖучок, А. Н., та Т. Н. Чернуха. "Ботулинотерапия гемифациального спазма: обзор литературы". Неврология и нейрохирургия. Восточная Европа 15, № 1 (2025): 94–104. https://doi.org/10.34883/pi.2025.15.1.058.
Full textLaskawi, R., and S. Rohrbach. "Selected Situations in the Treatment of Facial Hyperkinesis with Botulinum Toxin Type A." Otology & Neurotology 23, Sup 1 (2002): S90. http://dx.doi.org/10.1097/00129492-200200001-00234.
Full textArtemenko, A. R., O. A. Shavlovskaya, and E. R. Mkhitaryan. "Specificity of using botulinic toxin type A for blepharospasm treatment." Clinician 13, no. 3-4 (2020): 43–52. http://dx.doi.org/10.17650/1818-8338-2019-13-3-4-43-52.
Full textNeville, Catriona, Vanessa Venables, Margaret Aslet, Charles Nduka, and Ruben Kannan. "An objective assessment of botulinum toxin type A injection in the treatment of post-facial palsy synkinesis and hyperkinesis using the synkinesis assessment questionnaire." Journal of Plastic, Reconstructive & Aesthetic Surgery 70, no. 11 (2017): 1624–28. http://dx.doi.org/10.1016/j.bjps.2017.05.048.
Full textNitta, Naoki, Naotaka Usui, Akihiko Kondo, et al. "Semiology of hyperkinetic seizures of frontal versus temporal lobe origin." Epileptic Disorders 21, no. 2 (2019): 154–65. http://dx.doi.org/10.1684/epd.2019.1047.
Full textJudelson, Y. B., and N. Р. Gribova. "Exteroceptive suppression in facial hyperkineses and dystonias." Neurology Bulletin XXIX, no. 1-2 (1997): 88–90. http://dx.doi.org/10.17816/nb79930.
Full textDobie, R. A., and U. Fisch. "Primary and Revision Surgery (Selective Neurectomy) for Facial Hyperkinesia." Archives of Otolaryngology - Head and Neck Surgery 112, no. 2 (1986): 154–63. http://dx.doi.org/10.1001/archotol.1986.03780020034009.
Full textKim, Eugene J., Jay B. Reeck, and Corey S. Maas. "A Validated Rating Scale for Hyperkinetic Facial Lines." Archives of Facial Plastic Surgery 6, no. 4 (2004): 253–56. http://dx.doi.org/10.1001/archfaci.6.4.253.
Full textKula, Asl, Zeliha ne, and Vildan zel. "Effects of delay in botulinum toxin treatment on patients with hyperkinetic facial disorders." Annals of Medical Research 30, no. 12 (2023): 1. http://dx.doi.org/10.5455/annalsmedres.2023.09.262.
Full textGoodman, Greg. "Botulinum toxin for the correction of hyperkinetic facial lines." Australasian Journal of Dermatology 39, no. 3 (1998): 158–63. http://dx.doi.org/10.1111/j.1440-0960.1998.tb01272.x.
Full textVaranda, Sara, Sofia Rocha, Margarida Rodrigues, Álvaro Machado, and Gisela Carneiro. "Role of the “other Babinski sign” in hyperkinetic facial disorders." Journal of the Neurological Sciences 378 (July 2017): 36–37. http://dx.doi.org/10.1016/j.jns.2017.04.036.
Full textRamirez, Alexander L., Jay Reeck, and Corey S. Maas. "PRELIMINARY EXPERIENCE WITH BOTULINUM TOXIN TYPE B IN HYPERKINETIC FACIAL LINES." Plastic and Reconstructive Surgery 109, no. 6 (2002): 2154–55. http://dx.doi.org/10.1097/00006534-200205000-00061.
Full textLee, Yoon Se, Joong Ho Ahn, Hong Ju Park, et al. "Dual Coaptation of Facial Nerve Using Masseteric Branch of Trigeminal Nerve for Iatrogenic Facial Palsy: Preliminary Reports." Annals of Otology, Rhinology & Laryngology 129, no. 5 (2019): 505–11. http://dx.doi.org/10.1177/0003489419893722.
Full textRamirez, Alexander L., Jay Reeck, and Corey S. Maas. "Botulinum Toxin Type B (MyoBloc) in the Management of Hyperkinetic Facial Lines." Otolaryngology–Head and Neck Surgery 126, no. 5 (2002): 459–67. http://dx.doi.org/10.1067/mhn.2002.124706.
Full textManganelli, Fiore, Raffaele Dubbioso, Marcello Esposito, et al. "A case of congenital cataracts, facial dysmorphisms, neuropathy, and hyperkinetic movement disorder." Movement Disorders 28, no. 4 (2013): 559–60. http://dx.doi.org/10.1002/mds.25308.
Full textRohrich, Rod J., and Jeffrey E. Janis. "Botox for the Treatment of Dynamic and Hyperkinetic Facial Lines and Furrows: Adjunctive Use in Facial Aesthetic Surgery." Plastic and Reconstructive Surgery 112, Supplement (2003): 53S—54S. http://dx.doi.org/10.1097/01.prs.0000082193.79684.91.
Full textFagien, Steven. "Botox for the Treatment of Dynamic and Hyperkinetic Facial Lines and Furrows: Adjunctive Use in Facial Aesthetic Surgery." Plastic and Reconstructive Surgery 112, Supplement (2003): 40S—52S. http://dx.doi.org/10.1097/00006534-200310001-00007.
Full textFagien, Steven. "Botox for the Treatment of Dynamic and Hyperkinetic Facial Lines and Furrows: Adjunctive Use in Facial Aesthetic Surgery." Plastic and Reconstructive Surgery 103, no. 2 (1999): 701–13. http://dx.doi.org/10.1097/00006534-199902000-00055.
Full textMüller, Jörg, Gregor K. Wenning, Jörg Wissel, and Werner Poewe. "Intrafamilial heterogeneity of facial hyperkinesias: Chance association of tics, cranial dystonia, and Huntington's disease?" Movement Disorders 16, no. 2 (2001): 370–72. http://dx.doi.org/10.1002/mds.1058.
Full textAhn, Ki-Young, Mee-Yeong Park, Dae-Hwan Park, and Dong-Gil Han. "Botulinum Toxin A for the Treatment of Facial Hyperkinetic Wrinkle Lines in Koreans." Plastic and Reconstructive Surgery 112, Supplement (2003): 141S—147S. http://dx.doi.org/10.1097/00006534-200310001-00029.
Full textAhn, Ki-Young, Mee-Yeong Park, Dae-Hwan Park, and Dong-Gil Han. "Botulinum Toxin A for the Treatment of Facial Hyperkinetic Wrinkle Lines in Koreans." Plastic & Reconstructive Surgery 105, no. 2 (2000): 778–84. http://dx.doi.org/10.1097/00006534-200002000-00050.
Full textSvyrydova, N. K., Y. O. Trufanov, A. V. Artemenko, A. M. Rakhnianska, and S. O. Schurevskyy. "The Tourette’s syndrome: clinical case." East European Journal of Neurology, no. 1(7) (March 20, 2016): 12–17. http://dx.doi.org/10.33444/2411-5797.2016.1(7).12-17.
Full textKim, Eugene J., Alexander L. Ramirez, Jay B. Reeck, and Corey S. Maas. "The Role of Botulinum Toxin Type B (Myobloc) in the Treatment of Hyperkinetic Facial Lines." Plastic and Reconstructive Surgery 112, Supplement (2003): 88S—93S. http://dx.doi.org/10.1097/01.prs.0000082197.88799.84.
Full textRohrich, Rod J., and Jeffrey E. Janis. "The Role of Botulinum Toxin Type B (Myobloc) in the Treatment of Hyperkinetic Facial Lines." Plastic and Reconstructive Surgery 112, Supplement (2003): 94S—95S. http://dx.doi.org/10.1097/01.prs.0000082198.10443.9c.
Full textFagien, Steven. "The Role of Botulinum Toxin Type B (Myobloc) in the Treatment of Hyperkinetic Facial Lines." Plastic and Reconstructive Surgery 112, Supplement (2003): 96S—97S. http://dx.doi.org/10.1097/01.prs.0000082199.42730.2a.
Full textKeen, M., A. Blitzer, J. Aviv, et al. "Botulinum Toxin A for Hyperkinetic Facial Lines: Results of a Double-Blind, Placebo-Controlled Study." Ophthalmic Plastic & Reconstructive Surgery 12, no. 1 (1996): 69–70. http://dx.doi.org/10.1097/00002341-199603000-00019.
Full textKeen, Monte, Andrew Blitzer, Jonathan Aviv, et al. "Botulinum Toxin A for Hyperkinetic Facial Lines: Results of a Double-Blind, Placebo-Controlled Study." Plastic and Reconstructive Surgery 94, no. 1 (1994): 94–99. http://dx.doi.org/10.1097/00006534-199407000-00009.
Full textPetrov, Konstantin B., Natalya A. Ivonina, and Tatiana V. Mitichkina. "Motoric Automatisms of the Maxillofacial Region: a Lecture." Bulletin of Rehabilitation Medicine 21, no. 6 (2022): 145–55. http://dx.doi.org/10.38025/2078-1962-2022-21-6-145-155.
Full textBowler, Patrick J. "Dermal and epidermal remodeling using botulinum toxin type A for facial, nonreducible, hyperkinetic lines: two case studies." Journal of Cosmetic Dermatology 7, no. 3 (2008): 241–44. http://dx.doi.org/10.1111/j.1473-2165.2008.00399.x.
Full textVyskub, M. "Import substitution of botulinum toxin preparations in cosmetologist's practice: experience of using Miotox® preparation." Vrach 34, no. 7 (2023): 21–25. http://dx.doi.org/10.29296/25877305-2023-07-04.
Full textDanti, Federica Rachele, Serena Galosi, Marta Romani, et al. "GNAO1 encephalopathy." Neurology Genetics 3, no. 2 (2017): e143. http://dx.doi.org/10.1212/nxg.0000000000000143.
Full textSpiga Real, Daniel Sundfeld, Mateus Fagundes Goes, and Bianca Sato Fernandes. "Phenomenon of "Sismonasty" in the Use of Botulinum Toxin for Treatment of Hyperkinetic Facial Wrinkles: A Case Report." ARC Journal of Surgery 10, no. 1 (2024): 35–38. http://dx.doi.org/10.20431/2455-572x.1001005.
Full textMastrangelo, Mario, Chiara Commone, Carlo Greco, and Vincenzo Leuzzi. "TSC1 as a Novel Gene for Sleep-Related Hypermotor Epilepsy: A Child with a Mild Phenotype of Tuberous Sclerosis." Neuropediatrics 52, no. 02 (2021): 146–49. http://dx.doi.org/10.1055/s-0041-1722881.
Full textMcMillan, HJ, A. Telegrafi, A. Singleton, et al. "B.02 Recessive mutations in ATP8A2 cause severe hypotonia, cognitive impairment, hyperkinetic movement disorders and progressive optic atrophy." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 45, s2 (2018): S12. http://dx.doi.org/10.1017/cjn.2018.90.
Full textRomeo, Domenico M., Alessandro Specchia, Alfonso Fasano, et al. "Treatment of Dystonia Using Trihexyphenidyl in Costello Syndrome." Brain Sciences 10, no. 7 (2020): 450. http://dx.doi.org/10.3390/brainsci10070450.
Full textLerman-Sagie, Tally, Ana Westenberger, Hilla Ben-Pazi, et al. "Multiple Causes of Pediatric Early Onset Chorea—Clinical and Genetic Approach." Neuropediatrics 49, no. 04 (2018): 246–55. http://dx.doi.org/10.1055/s-0038-1645884.
Full textDolgopolov, I. S., L. Yu Grivtsova, O. K. Ustinova, and M. Yu Rykov. "Primary immunodeficiency in a patient with Kabuki syndrome." Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 67, no. 6 (2023): 104–12. http://dx.doi.org/10.21508/1027-4065-2022-67-6-104-112.
Full textNurul, Nasyifa, Billy Muchamad Ramdani, and Indra Gunawan Affandi. "Acute Hemiballismus Due to Vascular or Diabetic Striatopathy: A Rare Case Report from KHZ Musthafa General Hospital, Tasikmalaya." Magna Neurologica 3, no. 2 (2025): 99–103. https://doi.org/10.20961/magnaneurologica.v3i2.2276.
Full textVijiaratnam, Nirosen, Kailash P. Bhatia, Anthony E. Lang, Wendy H. Raskind, and Alberto J. Espay. "ADCY5–Related Dyskinesia: Improving Clinical Detection of an Evolving Disorder." Movement Disorders Clinical Practice 6, no. 7 (2019): 512–20. https://doi.org/10.1002/mdc3.12816.
Full textJha, Shreyashi, Netravathi M, Vikram Venkappayya Holla, Nitish Kamble, Anita Mahadevan, and Pramod Kumar Pal. "Movement disorders in autoimmune encephalitis: Clinical spectrum, prognosis, and outcomes from an Indian cohort." Annals of Movement Disorders 7, no. 3 (2024): 189–95. https://doi.org/10.4103/aomd.aomd_44_24.
Full textGorbunov, Alexey, Evgenii Tugolukov, Dmitry Parshin, Polina Polyanskaya, Alexey Loktev, and Marina Vlasova. "TIC HYPERKINESIS IN FIRST-YEAR STUDENTS AGED 17-19." Archiv Euromedica 14, no. 6 (2024). https://doi.org/10.35630/2024/14/6.605.
Full textErbguth, Frank, and Rüdiger Lange. "Sensory trick effect in craniofacial dystonia as one of the possible impacts of wearing face masks during the COVID-19 pandemic." Neurological Research and Practice 3, no. 1 (2021). http://dx.doi.org/10.1186/s42466-021-00123-2.
Full textMakhdoom, N., A. S. Chaudry, and Zhen Yu Wong. "373 The Use of Botulinum Toxin to Improve Cosmesis in Patients with Facial Asymmetry Following Facial palsy/synkinesis." British Journal of Surgery 111, Supplement_6 (2024). http://dx.doi.org/10.1093/bjs/znae163.509.
Full textDressler, D., and P. W. Sch�nle. "Botulinum toxin to suppress hyperkinesias after hypoglossal-facial nerve anastomosis." European Archives of Oto-Rhino-Laryngology 247, no. 6 (1990). http://dx.doi.org/10.1007/bf00179017.
Full textKhandelwal, Dinesh, Neha Pemassini, Ashish Pemawat, and Vaibhav Mathur. "ADCY5-related dyskinesias: An amalgamation of various hyperkinetic movement disorders." Annals of Movement Disorders, March 21, 2024. http://dx.doi.org/10.4103/aomd.aomd_35_23.
Full textShimojima Yamamoto, Keiko, Tomoe Yanagishita, Hisako Yamamoto, et al. "Recurrent de novo pathogenic variant of WASF1 in a Japanese patient with neurodevelopmental disorder with absent language and variable seizures." Human Genome Variation 8, no. 1 (2021). http://dx.doi.org/10.1038/s41439-021-00176-4.
Full text